BioCentury
ARTICLE | Company News

Aphios neurology, ophthalmic news

November 25, 2013 8:00 AM UTC

Aphios said it will spin off a wholly owned subsidiary, Amylon LLC, to develop and commercialize APH-1104 to treat mild to moderate Alzheimer's disease (AD) and other disorders, such as Down's syndro...